Levofloxacin Market
                     Levofloxacin 
Market
•(Pneumonia, Skin Infection, Kidney Infection, Bladder 
Infection, Others): Global Opportunity Analysis and Industry 
Forecast, 2023-2032
Prime determinants of growth  
Download Sample Copy of Report
Levofloxacin is an antibiotic that is sold under the trade name 
Levaquin and is used to treat many bacterial infections such as 
pneumonia, acute bacterial sinusitis, chronic prostatitis, and 
others. However, these medications also have certain side 
effects such as nausea, seizures, and diarrhea.
Recent developments in 
Levofloxacin Market
► Levofloxacin is an antibiotic that is 
Factors such as increasing incidences of 
sold under the trade name Levaquin 
bacterial infections such as pneumonia 
and is used to treat many bacterial 
& urinary tract infections (UTI) and 
infections such as pneumonia, acute 
broad spectrum efficacy drive the 
bacterial sinusitis, chronic prostatitis, 
market growth. However, side effects 
and others. However, these 
associated with levofloxacin such as 
medications also have certain side 
tendon inflammation, psychosis, and 
effects such as nausea, seizures, and 
seizures restrain the market growth.
diarrhea.
KEY PLAYERS:
Glenmark Dr. Reddys  Divine Savior 
Aden Healthcare Pax Healthcare
Pharmaceuticals Laboratories Ltd Healthcare
Lupin 
Allenge India Alna Biotech  Zydus Cadila. Bestochem Pharmaceuticals, 
Pharma Private Limited
Inc
BY REGION:
•North America (U.S.,
•Canada, Mexico)
•Europe (France, Germany, Italy,
•Spain, UK, Rest of Europe)
•Asia-Pacific (China, Japan, India, 
South Korea, Australia, Rest of Asia-
Pacific)
•LAMEA (Brazil, South Africa, Saudi 
Arabia, Rest of LAMEA)
•David Correa 
•5933 NE Win Sivers Drive 
•#205, Portland, OR 97220 
•United States 
CONTACT •Toll-Free: 1-800-792-5285 •UK: +44-845-528-1300 
US: •Hong Kong: +852-301-84916 
•India (Pune): +91-20-66346060 
•Fax: +1-855-550-5975 
•[email protected] 
•Web: https://www.alliedmarketresearch.com 
•Follow Us on: LinkedIn Twitter
THANK 
YOU !